【结 构 式】 |
【药物名称】LaaMII 【化学名称】N-(2-Aminododecanoyl)-glycyl-L-cysteinyl-L-cysteinyl-L-seryl-L-asparaginyl-L-prolyl-L-valyl-L-cysteinyl-L-histidyl-L-leucyl-L-glutamyl-L-histidyl-L-seryl-L-asparaginyl-L-leucyl-L-cysteine cyclic S-3.2-S-3.8:S-3.3-S-3.16-bis(disulfide) 【CA登记号】 【 分 子 式 】C79H125N23O24S4 【 分 子 量 】1909.2728 |
【开发单位】University of Queensland (Originator) 【药理作用】Cognition Disorders, Treatment of, NEUROLOGIC DRUGS, Smoking Cessation, Aid to, TREATMENT OF POISONING, DRUG ABUSE & DEPENDENCY, Treatment of Substance Dependency, Nicotinic alpha3 Antagonists |
合成路线1
Alkylation of diethyl acetamidomalonate (I) with 1-bromodecane (II) affords malonate (III). Subsequent hydrolysis and decarboxylation of (III) under acidic conditions leads to 2-aminododecanoic acid (IV). This is then protected as the N-Boc derivative (V) upon treatment with Boc2O and NaOH
【1】 Blanchfield, J.T.; Dutton, J.L.; Hogg, R.C.; Gallagher, O.P.; Craik, D.J.; Jones, A.; Adams, D.J.; Lewis, R.J..; Alewood, P.F.; Toth, I.; Synthesis, structure elucidation, in vitro biological activity, toxicity, and caco-2 cell permeability of lipophilic analogues of alpha-conotoxin MII. J Med Chem 2003, 46, 7, 1266. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 16710 | Diethyl 2-(acetamido)malonate; Diethyl acetamidomalonate | 1068-90-2 | C9H15NO5 | 详情 | 详情 |
(II) | 58570 | 1-Bromodecane; 1-Decyl bromide; Decyl bromide; n-decyl bromide | 112-29-8 | C10H21Br | 详情 | 详情 |
(III) | 63516 | diethyl 2-(acetylamino)-2-decylpropanedioate | C19H35NO5 | 详情 | 详情 | |
(IV) | 63517 | 2-aminododecanoic acid | C12H25NO2 | 详情 | 详情 | |
(V) | 63518 | 2-({[(1,1-dimethylethyl)oxy]carbonyl}amino)dodecanoic acid | C17H33NO4 | 详情 | 详情 |
合成路线2
The protected peptide-bound resin (VI) is prepared by solid-phase synthesis on a p-methylbenzhydrylamine resin, using HBTU/DIEA activation. Coupling of 2-(Boc-amino)dodecanoic acid (V) to the peptide resin (VI) by means of HBTU affords amide (VII). The DNP protecting groups of the histidine residues of (VII) are subsequently removed by treatment with 2-mercaptoethanol to provide (VIII). Further acidic cleavage of the N-terminal Boc group of (VIII) with trifluoroacetic acid leads to resin (IX). The linear peptide (X) is then cleaved from the resin by treatment with liquid (HF) in the presence of p-thiocresol
【1】 Blanchfield, J.T.; Dutton, J.L.; Hogg, R.C.; Gallagher, O.P.; Craik, D.J.; Jones, A.; Adams, D.J.; Lewis, R.J..; Alewood, P.F.; Toth, I.; Synthesis, structure elucidation, in vitro biological activity, toxicity, and caco-2 cell permeability of lipophilic analogues of alpha-conotoxin MII. J Med Chem 2003, 46, 7, 1266. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(V) | 63518 | 2-({[(1,1-dimethylethyl)oxy]carbonyl}amino)dodecanoic acid | C17H33NO4 | 详情 | 详情 |
合成路线3
Finally, air oxidation of the linear peptide (X) in a dilute solution of ammonium bicarbonate at pH 8 furnishes the desired bis-disulfide compound
【1】 Blanchfield, J.T.; Dutton, J.L.; Hogg, R.C.; Gallagher, O.P.; Craik, D.J.; Jones, A.; Adams, D.J.; Lewis, R.J..; Alewood, P.F.; Toth, I.; Synthesis, structure elucidation, in vitro biological activity, toxicity, and caco-2 cell permeability of lipophilic analogues of alpha-conotoxin MII. J Med Chem 2003, 46, 7, 1266. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(X) | 63524 | C13H25NO3GlyValLeu2Ser2Asn2GluHi | 详情 | 详情 |